Davis AK
Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, OH, USA. davis.5996@osu.edu.
ArticlePsilocybin
Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial.
ArticleDMT
Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.
PreprintDMT
5-MeO-DMT Use in Humans: A Scoping Review of Peer-Reviewed Research
ArticleDMT
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence.
ArticlePsilocybin
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.
ArticleMDMA
Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study.
ArticlePsilocybin
From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.
ArticleMDMA
Social Workers' Attitudes and Beliefs about MDMA-Assisted Therapy for Adolescents with PTSD.
ArticlePsychedelics
Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people.
ArticlePsilocybin
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial.
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticleAyahuasca
Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience.
ArticlePsilocybin
Psychedelic research at a crossroads.
ArticlePsilocybin
The Epidemiology of Psychedelic Use Among United States Military Veterans.
ArticlePsilocybin
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.
ArticleAyahuasca
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.
ArticleIbogaine
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico.
ArticlePsilocybin
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.
ArticlePsilocybin
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.
PreprintAyahuasca
Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study
PreprintAyahuasca
Increases in aesthetic experience following ayahuasca use: An open-label, naturalistic study
ArticlePsilocybin
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.
ArticlePsychedelics
Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United States and Canada.
ArticleIbogaine
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans.
ArticlePsychedelics
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.
ArticleDMT
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence.
ArticlePsilocybin
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.
ArticlePsilocybin
Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.
ArticlePsychedelics
Applying Lessons From Cannabis to the Psychedelic Highway: Buckle Up and Build Infrastructure.
ArticlePsilocybin
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.
ArticleDMT
The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
ArticlePsilocybin
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
ArticlePsilocybin
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
ArticlePsilocybin
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
ArticlePsilocybin
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.
ArticleMescaline
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.
ArticlePsilocybin
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
ArticleMescaline
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.
ArticlePsychedelics
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.
ArticlePsilocybin
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.
ArticlePsychedelics
Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color.
ArticlePsilocybin
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.
PreprintPsilocybin
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
ArticlePsilocybin
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy.
ArticleDMT
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
ArticlePsilocybin
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.
ArticleIbogaine
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans.
ArticleDMT
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.
ArticlePsychedelics
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
ArticlePsilocybin
Cessation and reduction in alcohol consumption and misuse after psychedelic use.
ArticlePsilocybin
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
ArticleDMT
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.
ArticlePsilocybin
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.
ArticleDMT
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
ArticleIbogaine